raghavendra_s
★    

2010-02-27 05:31
(5551 d 16:55 ago)

Posting: # 4829
Views: 5,736
 

 IP accountability [GxP / QC / QA]

Dear Sir,

In a BA/BE study if the query for Investigational products is not resolved on the check-in day or say if it is delayed and get resolved on the dosing day early morning, can the IP accountability and identification can be done or we should wait for the sponsor's response?

Thanks in advance,
Ohlbe
★★★

France,
2010-02-27 13:45
(5551 d 08:40 ago)

@ raghavendra_s
Posting: # 4831
Views: 4,646
 

 IP accountability

Dear Raghavendra,

❝ Dear Sir,


We also have some Ladies on the forum. Don't discourage them from answering.

❝ In a BA/BE study if the query for Investigational products is not resolved


❝ we should wait for the sponsor's response?


What query ? What response ? Sorry but I just don't understand what you're talking about.

Regards
Ohlbe

Regards
Ohlbe
raghavendra_s
★    

2010-03-01 08:15
(5549 d 14:11 ago)

(edited on 2010-03-01 11:49)
@ Ohlbe
Posting: # 4837
Views: 4,661
 

 IP accountability

Dear Madam/Sir,

Say any query related to IP which might supposed to be answered by sponsor only. Then what further action we may require to move-forward ?

Kind regards,



Edit: Full quote removed. Please delete anything from the text of the original poster which is not necessary in understanding your answer; see also this post! [Jaime]
Ohlbe
★★★

France,
2010-03-01 13:07
(5549 d 09:19 ago)

@ raghavendra_s
Posting: # 4838
Views: 4,782
 

 IP accountability

Dear Raghavendra,

Once again it depends on the question...

If the answer is absolutely needed before you can administer the product to the subjects (for instance the expiry date), then telling the sponsor no answer would result in postponing the trial usually helps to get a fast answer.

Whether you can already dispense/package the IMP depends on its primary packaging and on how you do the packaging yourself, I would say. If it is in a large bottle, or if you remove it from its blister: this is usually done on the day before dosing, for stability reasons. So if you're not sure to be able to dose, doing the dispensing/packaging may be a problem. If the IMP remains in its blister, then no problem to do the dispensing/packaging in advance.

Regards
Ohlbe

Regards
Ohlbe
UA Flag
Activity
 Admin contact
23,424 posts in 4,927 threads, 1,669 registered users;
119 visitors (0 registered, 119 guests [including 8 identified bots]).
Forum time: 23:26 CEST (Europe/Vienna)

We should not speak so that it is possible
for the audience to understand us,
but so that it is impossible
for them to misunderstand us.    Quintilian

The Bioequivalence and Bioavailability Forum is hosted by
BEBAC Ing. Helmut Schütz
HTML5